SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-19-004565
Filing Date
2019-03-08
Accepted
2019-03-08 07:00:43
Documents
4

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT s002621x24_8k.htm 425 48533
2 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CELGENE CO s002621x24_ex23-1.htm EX-23.1 5083
3 THE HISTORICAL AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENT s002621x24_ex99-1.htm EX-99.1 2959867
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF BRISTOL-MYERS SQ s002621x24_ex99-2.htm EX-99.2 340002
  Complete submission text file 0001140361-19-004565.txt   3355087
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Subject) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-34912 | Film No.: 19667582
SIC: 2834 Pharmaceutical Preparations